| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 338,562 | 344,876 | 315,850 | 303,169 | | Cost of Revenue | 247,422 | 247,264 | 233,409 | 229,297 | | | Gross Profit | 91,140 | 97,612 | 82,441 | 73,872 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,258 | 23,205 | 23,189 | 22,737 | | Non Recurring | 76 | 5,443 | (248) | 201 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 65,473 | 68,964 | 59,500 | 50,934 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,010) | 284 | 524 | 945 | | Earnings Before Interest And Taxes | 48,144 | 69,248 | 60,024 | 50,993 | | Interest Expense | (12,522) | 5,990 | 6,532 | 8,062 | | Income Before Tax | 60,666 | 63,258 | 53,492 | 42,931 | | Income Tax Expense | 23,180 | 24,290 | 20,611 | 17,240 | | Minority Interest |
-
|
-
|
-
| (886) | | | | Net Income From Continuing Ops | 34,227 | 38,968 | 32,881 | 25,691 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,227 | 38,968 | 32,881 | 25,691 | | Preferred Stock And Other Adjustments | 2,134 | (1,223) | (911) |
-
| | | Net Income Applicable To Common Shares | $36,361 | $37,745 | $31,970 | $25,691 |
|
0.51% Nasdaq 
0.21 (0.83%) 
Income Statement
